Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease

American Journal of Hematology

Volumn 82, Issue 10, 2007, Pages 881-886

  Melson, Joshua ^a,b   Jakate, Shriram ^a   Fung, Henry ^a   Arai, Sally ^a   Keshavarzian, Ali ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DACLIZUMAB; INFLIXIMAB; STEROID;

ADULT; ARTICLE; CLINICAL ARTICLE; DIARRHEA; DISEASE MARKER; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL ENDOSCOPY; GRAFT VERSUS HOST REACTION; HISTOLOGY; HUMAN; HUMAN TISSUE; INTESTINE CRYPT; MALE; MORTALITY; PARAMETER; PREDICTION; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

ACUTE DISEASE; ADRENAL CORTEX HORMONES; ADULT; APOPTOSIS; COLONOSCOPY; DIARRHEA; DRUG RESISTANCE; EPITHELIAL CELLS; FEMALE; GASTROINTESTINAL DISEASES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 34848926306     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20976     Document Type: Article

References (25)

1. McDonald GV, Shulman HM, Sullivan KM, et al. Intestinal and hepatic complications of human bone marrow transplantation, Part I. Gastroenterology 1986;90:460-477.
2. Mielcarek M, Martin PJ, Leisenring W, et al. Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood 2003;102:756-762.
3. Weisdorf D, Hakke R, Blazar B, et al. Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation. Transplantation 1991;51:1197-1203.
4. Iqbal N, Salzman D, Lazenby AJ, et al. Diagnosis of gastrointestinal graft-versus-host disease. Am J Gastroenterol 2000;95:3034-3038.
5. Couriel D, Humberto C, Champlin R, et al. Acute graft-versus-host disease: Pathophysiology, clinical manifestations, and management. Cancer 2004;101: 1936-1946.
6. Hings IM, Filipovich Ah, Miller WJ, et al. Prednisone therapy for acute graft-versus-host disease: Short-versus long term treatment. A prospective randomized control trial. Transplantation 1993;56:577-580.
7. Epstein RJ, McDonald GB, Sale GE, et al. The diagnostic accuracy of the rectal biopsy in acute graft-versus-host disease: A prospective study of 13 patients. Gastroenterology 1980;8:764-771.
8. Bombi J, Nadal A, Carreras E, et al. Assessment of histopathologic changes in the colonic biopsy in acute graft-versus-host disease. Am J Clin Pathol 1995;103:690-695.
9. Shidham VB, Chang CC, Shidham G, et al. Colon biopsies for evaluation of acute graft-versus-host disease in allogenic bone marrow transplant patients. BMC Gastroenterol 2003;3:5.
10. Snover DC, Weisdorf SA, Vercellotti GM, et al. A histopathologic study of gastric and small intestinal graft-versus-host disease following allogeneic bone marrow transplantation. Hum Pathol 1985;16:387-392.
11. Cox GJ, Matsui SM, Lo RS, et al. Etiology and outcome of diarrhea after marrow transplantation: A prospective study. Gastroenterology 1994;107:1398-1407.
12. Roy J, Snover DC, Weisdorf S, et al. Simultaneous upper and lower endoscopic biopsy in the diagnosis of intestinal graft-versus-host disease. Transplantation 1991;51:642-646.
13. Kumar S, Chen MG, Gastineau DA, et al. Prophylaxis of graft-versus-host disease with cyclosporine-prednisone is associated with increased risk of chronic graft-versus-host disease. Bone Marrow Transplant 2001;27:1133-1140.
14. Haskell H, Andrews CW, Reddy SI, et al. Pathologic features and clinical significance of backwash ileitis in ulcerative colitis. Am J Surg Path 2005;29: 1472-1481.
15. Sviland L, Pearson AD, Eastham EJ, et al. Histological features of skin and rectal biopsy specimens after autologous and allogeneic bone marrow transplantation. J Clin Pathol 1988;41:148-154.
16. Ponec RJ, Hackman Rc, McDonald GB, et al. Endoscopic and histologic diagnosis of intestinal graft-versus host disease after marrow transplantation. Gastrointest Endosc 1999;49:612-621.
17. Sviland L, Pearson AD, Green MA, et al. Prognostic importance of histological and immunopathological assessment of skin and rectal biopsies in patients with GVHD. BMT 1993;11:215-218.
18. Socie G, Mary JY, Daneshpoy M, et al. Prognostic value of apoptotic cells and infiltrating neutrophils in graft-versus-host disease of the gastrointestinal tract in humans TNF and Fas expression. Blood 2003;103: 50-57.
19. Washington K, Bentley RC, Green A, et al. Gastric graft-versus-host disease: A blinded histologic study. Am J Surg Path 1997;21:1037-1046.
20. Weisdorf D, Snover DC, Haake R, et al. Acute upper gastrointestinal graft-versus host disease: Clinical significance and response to immunosuppressive therapy. Blood 1990;76:624-629.
21. Wu D, Hockenbery Dm, Brentall TA, et al. Persistent nausea and anorexia after marrow transplantation. Transplantation 1998;66:1319-1324.
22. Snover DC. Graft-versus-host disease of the gastrointestinal tract. Am J Surg Pathol 1990;14S1:101-108.
23. Sale GE, McDonald GB, Shulman HM, et al. Gastrointestinal graft-versus-host disease in man. A clinicopathologic study of the rectal biopsy. Am J Surg Pathol 1979;3:291-299.
24. Cruz-Correa M, Poonawala A, Abraham SC, et al. Endoscopic findings predict the histologic diagnosis in gastrointestinal graft-versus-host disease. Endoscopy 2002;34:808-813.
25. Przepiorka D, Weisdorf D, Martin P, et al. 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant 1995;15:825-929.